Searchable abstracts of presentations at key conferences in endocrinology

ea0026p646 | Clinical case reports | ECE2011

Diabetes insipidus in a patient with breast carcinoma

Couto J , Santos A P , Martins R , Giesteira L , Torres I

Introduction: Central diabetes insipidus (CDI) is characterized by a deficient secretion of anti-diuretic hormone (ADH), in which a large volume of hypotonic urine is eliminated. Pituitary metastatic disease is rare, accounting for 1% of all excised pituitary tumors and generally involves the posterior pituitary. Neoplasms that more often originate pituitary metastases are breast and lung cancer. Breast cancer (BC) is associated with pituitary secondary involvement in 5.3 to 2...

ea0026p633 | Clinical case reports | ECE2011

Lower limb Merkel cell carcinoma with a single metastasis in a thyroid nodule

Martins R , Couto J , Santos A P , Ribeiro M , Giesteira L , Polinario A , Torres I

Introduction: Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous malignancy, affecting predominantly caucasian and older individuals (slight male predominance). This neoplasm is associated with a high risk of local recurrence and regional lymph node involvement. Distant metastases are less frequent; they were described in liver, bone, CNS, skin, lung and spleen. The authors describe a clinical case of Merkel cell carcinoma with a single metastasis in a thyroid nodule....

ea0049ep146 | Endocrine tumours and neoplasia | ECE2017

Glucose metabolism abnormalities and insulin resistance are frequent in well diferentiated digestive NETs

Santos Ana P , Santos Ana C , Castro Clara , Raposo Luis , Torres Isabel , Henrique Rui , Monteiro Mariana P , Cardoso M Helena

Introduction: Incidence of Digestive NETs (DNETs) has increased in the last 40 years. Visceral obesity, metabolic syndrome (MetS) and insulin resistance (IR) have been associated with several types of cancer.Aim: To evaluate possible associations of obesity, hyperinsulinemia and IR with well-differentiated (WD) DNETs through a case control study.Materials and methods: Ninety-six patients with gastrointestinal (75.0%) and pNET (22.9...

ea0021p112 | Clinical practice/governance and case reports | SFEBES2009

Somatostatin analogues as an alternative treatment for type 1 gastric endocrine tumour: case report

Santos Ana P , Martins Raquel G , Couto Joana , Barbosa Ana P , Abreu Nuno , Leca Luis , Torres Isabel

Introduction: Gastric endocrine tumors (GET) are rare. Type 1 tumors are non-functioning, almost exclusively benign lesions, usually presenting as multiple polyps, usually <1 cm in diameter, which arise from gastric enterochromaffin-like cells in response to chronically elevated gastrin, secondary to (auto-immune) atrophic fundic gastritis. These tumors were traditionally treated with total gastrectomy, like adenocarcinomas. Currently, surveillance or endoscopic treatment ...